Cargando…
Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number
In 2009, new EU legislation regulating advanced therapy medicinal products (ATMPs), consisting of gene therapy, tissue engineering and cell-based medicines, was introduced. Although less than 20 ATMPs were authorized since that time, the awarding of the Nobel Prize for Physiology or Medicine in 2018...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864901/ https://www.ncbi.nlm.nih.gov/pubmed/35197090 http://dx.doi.org/10.1186/s13062-022-00318-w |